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ABSTRACT: Bone has considerable potential for repair as illustrated by the phenomenon of fracture healing.
Repair and regeneration of bone recapitulate the sequential stages of development. It is well known that
demineralized bone matrix has the potential to induce new bone formation locally at a heterotopic site of
implantation. The sequential development of bone is reminiscent of endochondral bone differentiation during
bone development. The collagenous matrix-induced bone formation is a prototype model for matrix-cell inter-
actions in vivo. The developmental cascade includes migration of progenitor cells by chemotaxis, attachment
of cells through fibronectin, proliferation of mesenchymal cells, and differentiation of bone. The bone inductive
protein, osteogenin, was isolated by heparin affinity chromatography. Osteogenin initiates new bone formation
and is promoted by other growth factors. Recently, the genes for osteogenin and related bone morphogenetic
proteins were cloned and expressed. Recombinant osteogenin is osteogenic in vivo. The future prospects for
bone induction are bright, and this is an exciting frontier with applications in oral and orthopaedic surgery.
KEY WORDS: extracellular matrix (ECM), growth and morphogenetic factors, inductive interactions, bone
matrix, endochondral bone.
I. INTRODUCTION
One of the most exciting advances in bone
cell biology has been the recognition of the ex-
tracellular matrix (ECM) of bone as a multifac-
torial repository of locally active growth and mor-
phogenetic factors that modulate the function of
bone cells. -4 While in most cases their role in
vivo remains to be established definitively, it is
clear that growth and morphogenetic factors iso-
lated from the ECM of bone are potential mo-
lecular mediators of bone differentiation, main-
tenance, and repair. A remarkable example of
inductive interactions between the ECM of bone
and responding cells is the phenomenon of bone
formation by induction.5'6 Subcutaneous implan-
tation of demineralized bone matrix results in a
sequential developmental cascade of biochemical
and morphogenetic events culminating in local
differentiation of endochondral bone.7 The origins
of this research lie in the studies of Huggins,
Lacroix, Urist, Reddi and others who first used
biological assays to study the bone-inductive
properties of the ECM of bone and other tissues,
including tooth matrix and uroepithelium, and
then stimulated many groups to contribute to the
growing knowledge about the molecular and cel-
lular signals involved in endochondral bone
differentiation.
The growing appreciation that the ECM of
bone is a rich source of cellular modulators un-
derlies increasing interest in their role in repair
and regeneration of the bone-bone marrow organ.
These developments have arisen from a desire to
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understand fundamental developmental pro-
cesses; the control of cell differentiation, and the
generation of form. One expectation of this re-
search is the discovery of new regulatory agents
with novel biological and therapeutic potential.
The molecular dissection of the ECM of bone
has permitted the identification of an entirely new
family of protein initiators that regulate differ-
entiation of cartilage and bone in vivo.8-'0 Osteo-
genin, a protein initiator of bone differentiation,
has been purified recently from bovine bone ma-
trix and the amino acid sequence of several tryp-
tic peptides was determined and found to be
unique.'0 The amino acid sequence of bovine
osteogenin is identical to the amino acid sequence
deduced from the cDNA clones of one of the
human bone morphogenetic proteins (BMP),
BMP-3.9
The whole research into osteogenic initiators
is at a very exciting stage as it is likely in the
next few years that answers to questions of basic
research that have therapeutic implications for the
regeneration of bone in man will be found. This
review surveys the recent advances in the regu-
lation of bone development by osteogenin and
related bone morphogenetic proteins. Using the
postnatal bone development models to obtain a
conceptual framework of the cellular and molec-
ular mechanisms regulating endochondral bone
differentiation, we provide evidence for the po-
tential therapeutic application of osteogenin for
the architectural reconstruction of bone in man
based on cell biology of matrix-cell interactions.
II. THE POSTNATAL BONE
DIFFERENTIATION MODEL: A
DEVELOPMENTAL CASCADE
There is a direct relationship between growth
and differentiation processes in early develop-
ment and regeneration processes; fracture repair
may be considered to recapitulate events that oc-
cur in the normal course of embryonic bone de-
velopment. The tissue response elicited by sub-
cutaneous implantation of demineralized bone
matrix is reminiscent of embryonic bone devel-
opment. However, unlike the epiphyseal growth
plate, where a continuum of cartilage and bone
differentiation is observed, in the matrix-induced
implants single cycle of endochondral bone for-
mation is evident.2'7 The sequential develop-
mental cascade includes:67,1-s15 activation and
migration of undifferentiated mesenchymal cells
by chemotaxis; anchorage-dependent cell attach-
ment to the matrix via fibronectin; mitosis and
proliferation of mesenchymal cells; differentia-
tion of cartilage; mineralization of the cartilage;
vascular invasion and chondrolysis; differentia-
tion of osteoblasts and deposition of bone matrix;
and finally mineralization of bone and differen-
tiation of hemopoietic marrow in the newly de-
veloped ossicle.
Identification of osteogenic proteins in mam-
malian bone matrix has been a difficult task due
to the low abundance of osteogenin and related
BMPs tightly bound to the organic and inorganic
components of the ECM of bone. Progress is
recent years has been aided by four important
technical developments: the development of a
functional bioassay in the subcutaneous space of
the rat to monitor the specific biological activity
of osteogenic proteins;7'16'17 the development of
specific purification schemes involving heparin
affmiity chromatography;8 the use of electroen-
dosmotic elution techniques after preparative
sodium dodecyl sulfate gel electrophoresis to
achieve final purification homogeneity;'0 and fi-
nally the use of recombinantDNA methodologies
for the cloning and expression of several mem-
bers of the BMP family.9'18
A role for osteogenin and cell-substratum in-
teractions in the initiation of chondroblastic and
osteoblastic cell differentiation has been exten-
sively demonstrated both in vivo and in vi-
tro.4'10,19,20 Osteogenin, isolated from the extra-
cellular matrix of bone by heparin affinity
chromatography and purified to homogeneity by
electroendosmotic elution, in conjunction with
insoluble collagenous bone matrix, initiates the
developmental cascade of morphogenetic events
culminating in local differentiation of endochon-
dral bone in vivo.4'10 Instrumental to the purifi-
cation of osteogenin was the discovery that the
bone differentiating activity could be dissocia-
tively extracted from the ECM of bone and re-
constituted with the inactive insoluble collagen-
ous bone matrix residue, restoring the biological
activity of the extracted soluble osteogenic frac-
tions.'6 The bioassay by reconstitution of bioac-
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tive fractions obtained during the different steps
of the purification procedures, is a functional as-
say, and has permitted purification of native os-
teogenin from the ECM of bovine bone.4''0
The reproducible initiation of cartilage and
bone in the rat extraskeletal site using deminer-
alized bone matrix or osteogenin permits the dis-
section of the first wave of endochondral bone
development and mineralization,4'7 and enables
a systematic study of endogenous and exogenous
growth factors in bone development by the op-
erational dissection of the major steps in the se-
quential developmental cascade.2
III. CHARACTERIZATION, AMINO ACID
SEQUENCE, AND MOLECULAR
CLONING OF OSTEOGENIN AND
RELATED BONE MORPHOGENETIC
PROTEINS
Osteogenin and related BMPs are members
of the transforming growth factor-p (TGF-3) gene
family. TGF-P is a multifactorial regulator of cellu-
lar growth in developing systems,21 22 and it is a
prominent component of the ECM of bone.2325
While TGF-P molecules are most abundant in
the ECM of bone, their in vivo role in bone reg-
ulation is not clear. The TGF-3 gene family is
rapidly emerging as one of the most important
regulatory growth and differentiating factor su-
perfamily. The TGF-P family includes five dis-
tinct forms:26 the hormones activin and inhi-
bin;27'28 the Mullerian-inhibiting substance;29 the
Drosophila melanogaster decapentaplegic com-
plex;30 the Vg-1 gene product of Xenopus lae-
vis;31 and the Vg-1-related murine protein Vgr-
1.32 In addition, several subsets of BMPs are all
in the TGF-3 superfamily of molecules.9 The
biologically active native osteogenin (BMP-3),'0
the human recombinant BMP-2A,33 and BMP-
2B18 share limited homology with TGF-P
molecules.
The induction of bone in the rodent extra-
skeletal site demonstrates that native osteogenin
(BMP-3) and human recombinant BMP-2A and
2B orchestrate endochondral bone differentiation
in postnatal tissues, in a pattern highly reminis-
cent of the embryonic bone development. An
emerging body of evidence is now indicating that
osteogenic proteins may be involved in inductive
events that control pattern formation during em-
bryonic development.3435 The recent discovery
of specific binding sites for osteogenin in the
developing rat embryo with the highest concen-
tration in bone, cartilage, and surrounding con-
nective tissues, indicates that in addition to the
regeneration of bone, osteogenin may have a role
in skeletal differentiation morphogenesis.36 BMP-
2A RNA was localized in condensing precarti-
lagenous mesenchyme, and in the osteogenic
zones of developing bones in older mouse em-
bryos, indicating that BMP-2A may also regulate
cartilage and bone formation during embryogen-
esis.34 It is likely, however, that BMP gene prod-
ucts are also involved in morphogenetic pro-
cesses outside the developing skeletal system.
Thus, high levels of BMP-2A transcripts have
been localized in developing mouse hair and
whisker follicles, limb buds, tooth buds - in-
cluding the dental papilla and the odontoblastic
layer, and in the cranofacial mesenchyme, par-
ticularly in regions of precartilaginous mesen-
chymal condensations (Meckel's cartilage and




Bone induction is the result of the combi-
natorial action of osteogenin and the collagenous
matrix.4'10'38 It is likely that after the initiation of
the first wave of bone differentiation osteogenin,
including the commitment and the clonal expan-
sion of osteoprogenitor stem cells, the osteogenic
cascade may be promoted and maintained by a
variety of growth factors, including TGF-P.4 In-
deed, TGF-p was detected from day 9 onward
after subcutaneous implantation of bone matrix
in rats.39 The increased concentration correlated
with the onset of angiogenesis and calcification
of cartilage. TGF-P appeared to be compart-
mentalized in the mineral phase of the newly
formed bone matrix and this may be a mechanism
for storage of the latent or processed growth
factor.4.39
Vascular invasion is a prerequisite for bone
formation during endochondral bone differentia-
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tion.40'41 Angiogenesis is of paramount impor-
tance in fracture healing.42'43 In the matrix-de-
pendent bone induction model, angiogenesis is
correlated with chondrolysis and concomitant os-
teogenesis. These observations have prompted a
number of investigations into the interaction of
osteogenin with other components of the ECM
in an attempt to elucidate the combinatorial reg-
ulatory role of basement membrane components
and molecules of the TGF-P superfamily. These
studies have very recently demonstrated that both
osteogenin and TGF-3 bind to type IV colla-
gen.44 45 In addition, osteogenin binds also to type
I and type IX collagens.44 These findings provide
a conceptual framework for the supramolecular
assembly of the ECM of bone, and provide novel
insights into the regulatory role of growth factors
in the solid state. It is possible that type IV col-
lagen and other matrix components around the
endothelial cells of the invading capillaries may
bind growth and differentiating factors, and pres-
ent them locally in an immobilized form to re-
sponding mesenchymal cells and osteoprogeni-
tors to initiate osteogenesis.44 In view of the
affinity of both TGF-P molecules and osteogenin
for type IV collagen, Paralkar et al.4445 have
proposed that the biological actions of members
of the TGF-P superfamily molecules are regu-
lated by a complex interaction with ECM com-
ponents, and that type IV collagen may function
as a delivery system by sequestering both initi-
ators and promoters involved in endochondral
bone differentiation, as well as in other inductive
phenomena.
Novel information on the concept of the in-
structive role of matrix components in morpho-
genesis has been provided recently by Vukicevic
et al.,46 who investigated the interaction of rat
primary calvarial cells and the mouse osteoblast-
like cell line MC3T3-E1 with basement mem-
brane components. The results of these studies
have shown that osteoblastic cell lines recognized
components of basement membranes, i.e., lam-
inin and type IV collagen, undergo profound
morphological changes when cultured on a re-
constituted basement membrane gel.46 Taken to-
gether, these findings provide evidence for the
crucial role of basement membrane components
of invading blood vessels in osteogenesis. First,
macromolecules of the ECM may bind growth
and differentiating factors, protect them from
proteolytic degradation, modulate a controlled
slow release, and finally, orient them in an op-
timal conformation to locally initiate bone for-
mation.4445 Second, they modulate the pheno-
typic differentiation of osteoblastic cells. Thus,
the instructive role of theECM may be modulated
by the affinity of the matrix components for sol-
uble growth and differentiating factors in the solid
state, resulting in tissue patterning in embryonic
development,147 and locally regulating wound
healing and a variety of contact-dependent phys-
iological processes, including the matrix-depen-
dent endochondral bone differentiation model.4445
V. OSTEOGENIN AS THERAPEUTIC
INITIATOR OF OSTEOGENESIS: A
PRIMATE CALVARIAL MODEL
The purification of osteogenin and related
BMPs, and the operational dissection of the ma-
trix-dependent bone induction model have per-
mitted substantial progress in the elucidation of
the molecular and cellular mechanisms involved
in endochondral bone differentiation. However,
the morphogenetic potential of osteogenin and
related BMPs is solely based on work in ro-
dents.4 '0'33 Information concerning bone induc-
tion in primates is a prerequisite for the explo-
ration of potential therapeutic applications for the
regeneration of bone in man.48 There is a growing
interest in novel bone substitutes incorporating
osteogenic proteins for craniofacial and perio-
dontal applications in an effort to promote the
controlled initiation of bone formation, and to
reduce the harvest of autogenous bone and as-
sociated morbidity. The creation of a nonhuman
primate model, using species comparable to man
with respect to bone regulatory mechanisms and
bone remodeling, would closely replicate bone
repair and the biological fate of bone substitutes
in man, accelerating the pace of clinical trials.
We have studied the healing potential of cal-
varial defects in a series of adult individuals of
genus Papio (baboon), establishing a critical size
defect (CSD)-dependent nonunion of the baboon
calvaria,49 i.e., a defect that does not repair spon-
taneously with bone, requiring a graft of viable
bone or alternative substitutes to heal.50 The lim-
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FIGURE 1. Surgical exposure of the right calvaria in an adult male baboon, (A) Preparation of full-thickness
circular defects, 25 mm in diameter. Arrows indicate the location of the second defect trefined in the anterior region
of the calvaria. (B) Insertion of a 25-mm disc of insoluble collagenous matrix reconstituted with baboon osteogenin.
ited regenerative capacity of the membranous cal-
varial bones provides an ideal model to study the
osteogenetic potential of bone substitutes inde-
pendent of the weight-bearing component. A
considerable sexual dimorphism exists in the Pa-
pio species, the adult males being almost twice
the size of the females. Because of the relatively
large calvaria, four circular cranial defects, each
25 mm in diameter, can be surgically prepared
in an adult male without compromising the vas-
cular support of the intervening bone (Figure 1A).
This allows the simultaneous comparison within
the same animal ofbone substitutes with a control
defect and a graft of autogenous bone without
animal-to-animal variation, as systemic factors
may influence healing.49 In 48 adult male ba-
boons, calvarial defects were implanted with a
graft of autogenous bone harvested from the iliac
crest, and with different osteoconductive and os-
teoinductive substrata. These included baboon
insoluble collagenous bone matrix reconstituted
with osteogenin (Figure 1B), isolated and puri-
fied from baboon bone matrix,51'52 baboon de-
mineralized bone matrix, and insoluble collagen-
ous matrix without osteogenin. Forty-eight defects
were left ungrafted to monitor the spontaneous
regeneration potential of the adult baboon cal-
varia. Before calvarial implantation, osteogenin,
both isolated and purified from baboon and bo-
vine bone matrix and with biological activity in
rats (Figures 2A and B), were tested for biologic
activity in the rectus abdominis of an additional
16 baboons. The extraskeletal implantation per-
mits the unequivocal histological investigation of
bone formation by induction, avoiding possible
ambiguities of the orthotopic site (Figure 3).
Specimens with surrounding recipient cal-
variae were harvested at 1, 3, 6, and 9 months
after surgery, and histomorphometry was per-
formed on semithin undecalcified sections at 7
$xm, cut from plastic-embedded specimen blocks.
At 3 and 9 months, the amount of bone in control
defects was less than 14 and 20%, respectively
(Figure 4A). At 1 and 3 months, new bone for-
mation in autogeneic bone grafts was less than 8
and 24%, respectively (Figure 4B). Reconstitu-
tion of insoluble collagenous matrix with baboon
osteogenin-induced copious amounts of new bone
as early as 30d (Figure 5A), and at 3 months,
bone formation was extensive culminating in
complete regeneration of the craniotomy defects
(Figure 5B). In implants of demineralized bone
matrix bone formed with an intervening phase of
endochondral development and at 30 d large is-
lands of cartilage had differentiated within the
internal and central regions of the demineralized
bone matrix implants (Figures 6A and B). Car-
tilage formation in defects of membranous cal-
varial bone in adult primates is the phenotypic
evidence for bone development by induction, as
5
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IFIGURE 2. Endochondral bone differentiation in implants of rat insoluble collagenous matrix reconstituted with
baboon osteogenin fractions obtained after heparin-Sepharose, hydroxyapatite-Ultrogel, and S-200 Sephacryl chro-
matography (A), and baboon osteogenin purified to homogeneity after electroendosmotic elution (B). Reconstituted
implants were inserted in the subcutaneous space of 28 to 36-d-old Long Evans rats, and harvested 11 d after
implantation (Toluidine blue stain on 2-ixm sections cut from JB4 plastic-embedded specimens).
opposed to a merely passive osteoconductive pat-
tern of bone deposition from the margins of the
craniotomy defect.
VI. CARRIERS AND DELIVERY
SYSTEMS FOR THE BIOLOGICAL
EXPRESSION OF OSTEOGENIN AND
RELATED BMPS
The above-mentioned results in primates have
demonstrated that the association of osteogenin
with the complementary substratum of the col-
lagenous matrix can be exploited to construct
delivery systems for the rapid and controlled ini-
tiation of bone morphogenesis. The restoration
of biological activity after dissociative extraction
and reconstitution of osteogenin with insoluble
collagenous matrix'6 suggests that components of
the ECM of bone act as carriers for the functional
expression of osteogenin. Previous results have
shown that the collagenous bone matrix provides
an optimal substratum for anchorage of cells and
subsequent proliferation and differentiation.7 In
addition, the collagenous matrix may prevent
premature diffusion and dissolution of osteogenin
at the site of surgical implantation. This allows
a spatially controlled osteogenesis, restricting
bone differentiation in predetermined surgical
sites. While the reconstitution with insoluble col-
lagenous matrix is a requirement for optimum
delivery of biological activity,38 the collagenous
matrix, with its potential problems of antigenicity
and viral contamination, may limit the utilization
of osteogenin as a potential widespread thera-
peutic agent. A major goal of the combined ef-
forts of biomaterial scientists and reconstructive
surgeons is the development of delivery systems
and substrata capable of restoring the optimal
expression of the biological activity of osteogenin
in the absence of the organic substratum of the
collagenous matrix.
By exploiting the biological principle of cen-
tripetal mesenchymal tissue ingrowth,53 porous
biomaterials appear to be best suited for the con-
struction of delivery systems for osteogenin. We
have investigated the osteogenic potential of os-
teogenin combined with porous hydroxyapatite
replicas obtained after hydrothermal conversion
of calcium carbonate exoskeletons of corals.5459
The results have shown that osteogenin, adsorbed
on hydroxyapatite substrata, induced in vivo dif-
ferentiation of the osteogenic phenotype in mes-
enchymal cells populating the tridimensional po-
rous framework of the hydroxyapatite substratum
when implanted extraskeletally in rodents83 (Fig-
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FIGURE 3. Bone differentiation in 30-d implants of baboon insoluble collagenous matrix reconstituted with baboon(A and B), and bovine (C) osteogenin fractions obtained after S-20 Sephacryl gel filtration and implanted extras-keletally in baboons (rectus abdominis). (A) N of cartilage (open arrow) invading the insoluble collagenous matrix.(B) High-power view showing osteoblasts lining newly formed bone with embedded osteocytes (arrowheads). (C)
Extensive bone formation, remodeling, and dissolution of the implanted collagenous matrix. Arrows indicate con-
tiguous layers of osteoblasts lining newly formed trabeculae of induced bone. (D) Bone differentiation after extras-
keletal implantation of baboon demineralized bone matrix in an adult baboon.
ure 7). Interestingly, intramuscular implantation
of porous hydroxyapatite replicas in baboons re-
sulted in bone formation within the porous spaces(Figures 8A and B), irrespective of the osteogenic
stimulus of osteogenin,60'61 underscoring the im-
portance of primates when investigating the os-
teogenic potential of bone substitutes for clinical
application in man.62 The realization that the bi-
ological activity of osteogenin can be restored
and delivered by inorganic porous substrata to
obtain predictable phenotypes with complete host
acceptance and incorporation, will help to design
appropriate delivery systems for the controlled
initiation and promotion of bone morphogenesis
for craniofacial and periodontal applications.
VII. CRANIOFACIAL AND PERIODONTAL
APPLICATIONS
The architectural and functional reconstruc-
tion of the craniofacial skeletal tissues lost as a
consequence of disease and trauma is a formi-
dable challenge for modem surgery, and neces-
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FIGURE 4. Photomicrographs of calvarial specimens harvested 90 d after surgery. (A) Low-power photomicro-graph of a section from an untreated calvarial defect. Arrows indicate the original margins of the craniotomypreparation. Minimal bone deposition within the defect. (B) Photomicrograph of an autogeneic bone graft harvestedfrom the iliac crest showing pericranial and endocranial bone deposition (arrowed) along the implanted scaffold
near the calvaria-graft interface (right) but absent toward the central region of the implant (modified Goldner's
trichrome stain on undecalcified sections at 7 ,m).
FIGURE 5. Photomicrographs of calvarial specimens of insoluble collagenous matrix reconstituted witn oaooon
osteogenin fractions. (A) Central region of a section prepared from a specimen 30 d after implantation. Extensive
bone formation, rapid incorporation and dissolution of the implanted matrix, and formation of solid trabeculae of
mineralized bone. Low-power photomicrograph of a section of osteogenin-reconstituted baboon insoluble colla-
genous matrix harvest 90 d after implantation in a calvarial defect. Arrows indicate the margins of the craniotomy
preparation. Extensive bone formation with complete regeneration of the defect.
sitates the combined efforts of molecular and cel-
lular biologists, biomaterial scientists, and
reconstructive surgeons. The use of osteogenin
and related BMPs in reconstructive procedures
is a fertile area of applied research and holds
realistic potential for the therapeutic regeneration
of bone, including the correction of congenital
and acquired craniofacial anomalies.63
Regeneration of the periodontal tissues fol-
lowing destructive episodes of inflammatory-in-
fective periodontal diseases is an even more chal-
lenging problem, since repair processes must
involve not only the affected alveolar bone, but
other crucial components, i.e., the periodontal
ligament and the root cementum. The final goal
is the formation of new connective tissue attach-
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FIGURE 6. Photomicrographs of a section of a calvarial specimen of baboon demineralized bone matrix harvested
30 d after implantation. (A) Low-power photomicrograph showing endochondral bone differentiation in the central
region of the implant. Arrows indicate the dural layer. (B) High-power view illustrating the intervening cartilage phase
after implantation of demineralized bone matrix (DBM) in calvarial defects.
ment with functional orientated periodontal lig-
ament fibers inserted into newly formed cemen-
tum, and the organization of a competent gingival
unit. Provided the root surface is adequately de-
contaminated, three major biological problems
are faced by practicing periodontists and re-
searchers alike:4 establishment of connective tis-
sue attachment to highly mineralized, almost im-
permeable cemental or dentinal surfaces after root
planing; promotion of osteogenesis; and inhibi-
tion of apical migration of gingival epithelial cells.
The latter problem has been addressed by the
development of strategies that mechanically guide
and control tissue regeneration by selectively ex-
cluding epithelial cells to participate in the heal-
ing process adjacent to the prepared root sur-
faces.65 66 More recently, the concept of
biochemically mediated tissue regeneration has
emerged as a potential therapeutic approach to
the reconstruction of the periodontal unit.67-72 Ex-
posure of dentinal collagen type I after citric
acid73'74 or tetracycline-HC167 surface deminer-
alization has been followed by the exogenous
application of attachment factors such as fibro-
nectin and laminin,68-71,75 to enhance fibroblast
migration, attachment, and collagen synthesis,
and to inhibit apical proliferation of junctional
epithelial cells. Promising preliminary results have
been obtained using a combination of platelet-
derived growth factor (PDGF) and insulin-like
growth factor in a canine periodontal wound
model.76 The use of PDGF in periodontal surgery
is appealing since it has been demonstrated that
supplementation of PDGF resulted in enhance-
ment of cartilage and bone formation in condi-
tions where bone induction was subminimal.77
This may have important therapeutic implications
in the treatment of impaired bone formation in
the aged, particularly in instances of periodontal
disease.
So far, osteogenin and human recombinant
BMPs have not been tested as potential initiators
of osteogenesis for the experimental treatment of
periodontal conditions. However, a number of
studies using crude bone matrix preparations have
suggested that demineralized freeze-dried allo-
geneic bone has therapeutic potential for bone
and connective tissue regeneration in humans.78
82 From a therapeutic point of view, future re-
search should focus on the delivery of osteogenin
and related BMPs in combination with collagen-
ous matrix or porous biomaterials to regulate bone
formation in periodontal regenerative proce-
dures. With the complexity of the periodontal
disease process, it is likely that enhanced bone
resorption may be coupled with inhibited bone
deposition,83 particularly when related to cyclic
periods of disease activity. In conditions of lim-
ited bone formation, local delivery of osteogenin
and related BMPs may initiate the osteogenetic
9
FIGURE 7. Bone differentiation in an implant of porous coralline hydroxy-
apatite (HA) and bovine osteogenin 11 d after implantation in the subcutaneous
space of 28- to 36-d-old Long Evans rats. Arrows indicate contiguous layers
of osteoblasts. Plastic-embedded section at 2 axm stained with toluidine blue.
I
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FIGURE 8. Photomicrographs of bone differentiation in porous hydroxyapatite specimens implanted in the rectus
abdominis of adult baboons. (A) Control hydroxyapatite implant without osteogenin. Note the extensive bone
deposition, remodeling, and organization of lamellar bone 6 months after surgical implantation. (B) Bone differ-
entiation in the porous spaces of a porous hydroxyapatite and bovine osteogenin specimen harvested 90 d after
implantation. Paraffin-embedded sections at 5 am stained with toluidine blue.
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stimulus necessary for the regeneration of the
periodontal unit.
VIII. CONCLUSIONS
The molecular biology and biochemistry of
protein initiators of bone differentiation are be-
coming increasingly defined. Osteogenin and re-
lated BMPs are members of the TGF-P supergene
family, and are involved in a number of physi-
ological events that include embryonic devel-
opment, skeletal tissue maintenance and repair.
The interaction of osteogenin with other ECM
components has permitted a conceptual design of
the possible regulatory role of growth and initi-
ating factors in the solid state. This wealth of
knowledge can now be applied to controlling the
rapid initiation of bone formation for craniofacial
and periodontal conditions in man.
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